Viewing Study NCT04480333


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-03-01 @ 12:32 PM
Study NCT ID: NCT04480333
Status: UNKNOWN
Last Update Posted: 2020-07-21
First Post: 2020-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
Sponsor: Biomed Industries, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module